Actively Recruiting

Phase 4
Age: 18Years - 80Years
All Genders
NCT06784999

Sufentanil Infusion vs Intravenous Methadone for Postoperative Analgesia Following Head and Neck Dissection With Free Flap or Rotational Reconstruction

Led by Indiana University · Updated on 2026-05-01

128

Participants Needed

1

Research Sites

146 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The main purpose of this study is to determine which type of medication, sufentanil or methadone, is better at controlling pain during and, more importantly, after surgery in patients undergoing a head and neck dissection with free flap or rotational tissue reconstruction. Prior to their operation, subjects will be randomized to receive either Sufentanil or Methadone. After surgery, research staff will obtain information about recovery and pain levels.

CONDITIONS

Official Title

Sufentanil Infusion vs Intravenous Methadone for Postoperative Analgesia Following Head and Neck Dissection With Free Flap or Rotational Reconstruction

Who Can Participate

Age: 18Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients undergoing head and neck dissection with free flap or rotational reconstruction at Indiana University Health Adult Academic Health Center
  • ASA class 1, 2, or 3
  • Age between 18 and 80 years
  • Male or female
  • Able and willing to provide written informed consent
Not Eligible

You will not qualify if you...

  • Any contraindication to opiates, including allergy to opioids or substance use disorder
  • Currently on home methadone at any dose
  • Physical, mental, or medical conditions that may affect measuring postoperative pain
  • Known true allergy to sufentanil or methadone
  • History of substance abuse in the past 6 months, including heroin or illegal drugs
  • End stage liver disease or end stage renal disease
  • Patient remaining intubated or on mechanical ventilation after surgery
  • Taking more than 30 mg oral morphine equivalent per day at home
  • Undergoing additional or concurrent surgical procedures

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Indiana University

Indianapolis, Indiana, United States, 46202

Actively Recruiting

Loading map...

Research Team

L

Lyla S Farlow

CONTACT

A

Angie M Plummer

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here